Blair William & CO Axsome Therapeutics, Inc. Transaction History

Blair William & CO

$33.4 Billion
Q3 2024

A detailed history of Blair William & CO transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Blair William & CO holds 55,170 shares of AXSM stock, worth $5.14 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

55,170

Previous 59,151 6.73%

Holding current value

$5.14 Million

Previous $4.76 Million 4.12%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$78.93 - $95.84 $314,220 - $381,539	-3,981 Reduced 6.73%	55,170 $4.96 Million
Q2 2024 Aug 12, 2024	SELL	$65.72 - $80.5 $288,905 - $353,878	-4,396 Reduced 6.92%	59,151 $4.76 Million
Q1 2024 May 09, 2024	BUY	$69.39 - $97.64 $3.82 Million - $5.37 Million	55,027 Added 645.86%	63,547 $5.07 Million
Q4 2023 Feb 12, 2024	SELL	$57.42 - $83.61 $215,325 - $313,537	-3,750 Reduced 30.56%	8,520 $678,000
Q3 2023 Nov 09, 2023	BUY	$69.25 - $82.21 $27,700 - $32,884	400 Added 3.37%	12,270 $857,000
Q2 2023 Aug 11, 2023	SELL	$58.41 - $90.35 $96,668 - $149,529	-1,655 Reduced 12.24%	11,870 $852,000
Q1 2023 May 12, 2023	BUY	$58.39 - $75.0 $243,778 - $313,125	4,175 Added 44.65%	13,525 $834,000
Q4 2022 Feb 10, 2023	SELL	$39.94 - $79.72 $57,513 - $114,796	-1,440 Reduced 13.35%	9,350 $721,000
Q3 2022 Nov 09, 2022	SELL	$36.06 - $69.85 $219,966 - $426,084	-6,100 Reduced 36.12%	10,790 $481,000
Q2 2022 Aug 10, 2022	BUY	$21.74 - $46.75 $37,023 - $79,615	1,703 Added 11.21%	16,890 $647,000
Q1 2022 May 13, 2022	SELL	$23.7 - $41.39 $21,330 - $37,251	-900 Reduced 5.59%	15,187 $629,000
Q4 2021 Feb 14, 2022	SELL	$30.7 - $43.36 $76,443 - $107,966	-2,490 Reduced 13.4%	16,087 $608,000
Q3 2021 Nov 12, 2021	BUY	$19.91 - $68.26 $200,095 - $686,013	10,050 Added 117.86%	18,577 $612,000
Q2 2021 Aug 12, 2021	SELL	$50.63 - $73.5 $4,050 - $5,880	-80 Reduced 0.93%	8,527 $575,000
Q1 2021 May 13, 2021	SELL	$55.91 - $81.44 $428,270 - $623,830	-7,660 Reduced 47.09%	8,607 $487,000
Q4 2020 Feb 09, 2021	BUY	$66.31 - $86.52 $137,593 - $179,529	2,075 Added 14.62%	16,267 $1.33 Million
Q3 2020 Nov 06, 2020	BUY	$68.34 - $85.84 $8,200 - $10,300	120 Added 0.85%	14,192 $1.01 Million
Q2 2020 Aug 12, 2020	BUY	$49.87 - $98.69 $380,607 - $753,202	7,632 Added 118.51%	14,072 $1.16 Million
Q1 2020 May 11, 2020	SELL	$41.2 - $101.31 $465,230 - $1.14 Million	-11,292 Reduced 63.68%	6,440 $379,000
Q4 2019 Feb 13, 2020	BUY	$16.71 - $106.24 $296,301 - $1.88 Million	17,732 New	17,732 $1.83 Million

Others Institutions Holding AXSM

# of Institutions

326

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.99B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account